Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ribosomal read through as an alternative therapy for patients with hemophilia with nonsense mutations

Journal of Thrombosis and Haemostasis(2025)10.1016/j.jtha.2025.09.023Source: DataRank Database

Ribosomal read through as an alternative therapy for patients with hemophilia with nonsense mutations is a research paper published in Journal of Thrombosis and Haemostasis (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: closedTopics (24)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Vishal Srivastava ORCID,Aabid Hussain ORCID,Bin Zhang ORCID,Zhigang Liu ORCID

Live enrichment

PubMed:41083003 PMC:PMC12614837 OpenAlex:https://openalex.org/W4415070228

National Heart Lung and Blood Institute Division of Intramural Research

Grant: HL094505

National Heart Lung and Blood Institute Division of Intramural Research

Grant: HL169427

NHLBI NIH HHS

Grant: R01 HL169427

NHLBI NIH HHS

Grant: R01 HL094505

National Institutes of Health

FWCI

0.00

Citation Percentile

0.3%

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1538783625006154?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783625006154?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2025.09.023

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41083003

Fields of Study

Hemophilia Treatment and ResearchComplement system in diseasesVirus-based gene therapy research

MeSH Terms

AnimalsDisease Models, AnimalFactor VIIIGentamicinsHemophilia AHumansLuciferasesRibosomesCodon, NonsenseMiceHEK293 Cells

Keywords

Nonsense mutationNonsenseMutationRibosomal RNAGenetic enhancementHemophilia ANonsense Mutations2,6-DiaminopurineElx-02Ribosomal Readthrough

Ribosomal read through as an alternative therapy for patients with hemophilia with nonsense mutations

FAIR Checklist

Authors (4)

Funding (5 grants)

Impact

Open Access

Topics